In a subset of patients with mild to moderate Alzheimer’s and evidence of severe gum disease due to P. gingivalis infection, treatment…
Articles by Yedida Y Bogachkov PhD
Athira Pharma has completed enrollment in its ACT-AD Phase 2 trial evaluating the safety and efficacy of ATH-1017…
Eisai has started work on a rolling submission to the U.S. Food and Drug Administration (FDA) for a Biologics…
Athira Pharma, Inc will initiate an open-label extension study for two ongoing clinical trials investigating ATH-1017 to treat Alzheimer’s disease.
People affected by Alzheimer’s disease and related dementias are invited to register for the Mayo Clinic Conference on…
Amyloid-beta produced in peripheral organs, specifically the liver, may be implicated in the brain neurodegeneration observed in Alzheimer’s disease, according…
Research institutions in North Carolina and Texas have become the newest members of a national network of Alzheimer’s Disease…